Opko Health Inc OPK

NAS: OPK | ISIN: US68375N1037   26/05/2023
1,410 USD (-0,70%)
(-0,70%)   26/05/2023

9 februari 2023 · BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings · Persbericht

16 maart 2022 · GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions · Persbericht

1 maart 2022 · Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease · Persbericht

29 november 2021 · BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S. · Persbericht

21 september 2021 · GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes · Persbericht

16 augustus 2021 · BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business · Persbericht

22 juni 2021 · BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry · Persbericht

27 april 2021 · Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year · Persbericht

1 april 2021 · BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball · Persbericht

26 maart 2021 · BioReference Laboratories Expands COVID-19 School Testing Program · Persbericht

3 februari 2021 · OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021 · Persbericht

26 januari 2021 · OPKO Health's GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia · Persbericht

26 januari 2021 · OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing · Persbericht

13 januari 2021 · OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access · Persbericht

5 januari 2021 · OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

4 januari 2021 · OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide · Persbericht

Mijn selecties